key: cord-0951641-0yucgj3l
authors: Zheng, Zhe; Pitzer, Virginia E.; Shapiro, Eugene D.; Bont, Louis J.; Weinberger, Daniel M.
title: Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
date: 2021-12-16
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2021.41779
sha: a010d52899ea489821342ff9b7cd5c1880bc0c0a
doc_id: 951641
cord_uid: 0yucgj3l

IMPORTANCE: Respiratory syncytial virus (RSV) is a leading cause of hospitalizations in young children. RSV largely disappeared in 2020 owing to precautions taken because of the COVID-19 pandemic. Estimating the timing and intensity of the reemergence of RSV and the age groups affected is crucial for planning for the administration of prophylactic antibodies and anticipating hospital capacity. OBJECTIVE: To examine the association of different factors, including mitigation strategies, duration of maternal-derived immunity, and importation of external infections, with the dynamics of reemergent RSV epidemics. DESIGN, SETTING, AND PARTICIPANTS: This simulation modeling study used mathematical models to reproduce the annual epidemics of RSV before the COVID-19 pandemic in New York and California. These models were modified to project the trajectory of RSV epidemics from 2020 to 2025 under different scenarios with varying stringency of mitigation measures for SARS-CoV-2. Simulations also evaluated factors likely to affect the reemergence of RSV epidemics, including introduction of the virus from out-of-state sources and decreased transplacentally acquired immunity in infants. Models using parameters fitted to similar inpatient data sets from Colorado and Florida were used to illustrate these associations in populations with biennial RSV epidemics and year-round RSV circulation, respectively. Statistical analysis was performed from February to October 2021. MAIN OUTCOMES AND MEASURES: The primary outcome of this study was defined as the estimated number of RSV hospitalizations each month in the entire population. Secondary outcomes included the age distribution of hospitalizations among children less than 5 years of age, incidence of any RSV infection, and incidence of RSV lower respiratory tract infection. RESULTS: Among a simulated population of 19.45 million people, virus introduction from external sources was associated with the emergence of the spring and summer epidemic in 2021. There was a tradeoff between the intensity of the spring and summer epidemic in 2021 and the intensity of the epidemic in the subsequent winter. Among children 1 year of age, the estimated incidence of RSV hospitalizations was 707 per 100 000 children per year in the 2021 and 2022 RSV season, compared with 355 per 100 000 children per year in a typical RSV season. CONCLUSIONS AND RELEVANCE: This simulation modeling study found that virus introduction from external sources was associated with the spring and summer epidemics in 2021. These findings suggest that pediatric departments should be alert to large RSV outbreaks in the coming seasons, the intensity of which could depend on the size of the spring and summer epidemic in that location. Enhanced surveillance is recommended for both prophylaxis administration and hospital capacity management.

Mathematical models were used to reproduce the annual RSV epidemics before the COVID-19 pandemic based on the inpatient data of New York (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) and California (2003 California ( -2011 . Parameters to produce biennial RSV epidemics and year-round RSV activity were taken from models fit to similar datasets from Colorado and Florida (1989 Florida ( -2009 , respectively. This model assumes infants are born with transplacentally-acquired antibodies against RSV infections from their mothers (M). As transplacentally-acquired protective antibodies wane, infants become susceptible to infection (S 0 ). Following each infection (I i ), individuals gain partial immunity that lowers both their susceptibility to subsequent infections and the duration and infectiousness of subsequent infections (see eFigure 1). The force of infection for a specific age group , ( ), for time t is defined as:

Seasonality in the force of infection is represented by (1 + 1 cos( 2 − 12 )), where 1 is the amplitude of seasonality and ϕ is the seasonal offset. The chance of susceptible individuals in age group being infected is influenced by their contacts with infectious individuals in the entire population. , is the transmission rate from age group k to age group . The proportion of infected individuals and their relative infectiousness at time t is denoted by ( 1, ( ) + 1 2, ( ) + 2 3, ( ) + 2 4, ( ))⁄ ( ), where 1, is the number of infectious individuals of age k during their first infection; 2, , 3, and 4, are the number of infectious individuals who have been infected two, three and four or more times, respectively; 1 and 2 denote the relative infectiousness of the second and subsequent infections; and N k is the total population of age k.

The transmission parameter , can be further decomposed into the age-specific contact probability between age group and per unit time ( , ) and the probability of transmission given contact between an infectious and a susceptible individual (q). Age-specific mixing patterns were obtained from several previous studies, including detailed contact patterns for infants under 1 year of age and location-specific contact patterns. [1] [2] [3] Age was stratified into thirteen groups: infants younger than 3 months, 3-5 months, 6-8 months, 9-11 months, 1 year, 2 years, 3 years, 4 years, 5-9 years, 10-19 years, 20-39 years, 40-59 years, and ≥60 years.

The disease transmission process is linked to observation-level information. The probabilities of developing lower respiratory tract disease and being hospitalized upon RSV infection are informed by cohort studies conducted in the US and Kenya. 1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The number of lower respiratory tract infections (LRI) due to RSV is given by: where ( ) is the force of infection for a specific age group at time t (as defined above). 0, is the number of fully susceptible individuals of age a; 1, , 2, and 3, are the number of susceptible individuals who have been infected once, twice and more times, respectively. 1 , 2 and 3 denote the relative risk of infection following the first, second, and more infections. ℎ 1, , ℎ 2, and ℎ 3, are the proportion of the first, second, and more infections that are hospitalized.

The average age of hospitalization among children under 5 in month t is given by: 15

where the weight is the midpoint of age group .

Several model parameters were fixed based on data from previous cohort and modeling studies. 1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] We used Bayesian inference to estimate the average duration of transplacentally-acquired immunity, age-specific probability of hospitalization in the 40-59 year and >60 year age groups, the transmissibility coefficient, and seasonal parameters by fitting the model to the hospitalization data from New York and California. 16, 17 We identified the best-fit parameter sets by maximum a posteriori estimation. 18 The likelihood was calculated by assuming the observed number of hospitalizations in the entire population was Poisson-distributed with a mean equal to the model-predicted number of hospitalization, and that the observed age distribution was multinomialdistributed with probabilities equal to the model-predicted distribution of RSV hospitalizations in each age group.

To validate our model predictions, we fitted the transmission model to the inpatient data for California from 2003 to 2011; we then compared the model predictions with data on the percent of clinical specimens positive for RSV from a separate sentinel surveillance database from 2012 to 2018. We rescaled the percent positive data by calculating a scaling factor based on overlaying the surveillance data and inpatient data from 2009 to 2011 (see eFigure 3).

We initialized the transmission models with 1 infectious individual in each age group (except for infants under 6 months) in July 1981 and used a burn-in period of 24 years and 22 years in New York and California, respectively. We also performed a sensitivity analysis around what re-emergence might look like in a state with a biennial pattern of epidemics, using parameters fitted to earlier data from Colorado as an example and assuming a linearly declining birth rate (from 17 to 10 births per 1,000 people per year). We used the same number of infectious individuals to initialize transmission model, and a burn-in period of 40 or 41 years starting from 1971 or 1970 to allow for greater incidence in even or odd years. The numbers on the top show the percentage difference between the expected incidence and the counterfactual incidence in each age group.

Projecting social contact matrices in 152 countries using contact surveys and demographic data

The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young

Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease

The progression of maternal RSV antibodies in the offspring

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

Respiratory syncytial virus infections within families. The New England journal of medicine

Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. The Journal of infectious diseases

Viral shedding and immune responses to respiratory syncytial virus infection in older adults

Respiratory syncytial virus shedding by children hospitalized with lower respiratory tract infection

Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding. Epidemiology and infection

Exploring the relationship between incidence and the average age of infection during seasonal epidemics

Bayesian Methods for Calibrating Health Policy Models: A Tutorial

Bayesian melding for estimating uncertainty in national HIV prevalence estimates

The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya

Respiratory syncytial virus infections in infants: quantitation and duration of shedding. The Journal of pediatrics

The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections

Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States

Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort. The Journal of infectious diseases

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Incidence of respiratory syncytial virus related health care utilization in the United States

Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life. European journal of pediatrics

Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials

Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI)

Quantifying population contact patterns in the United States during the COVID-19 pandemic

Measuring voluntary and policyinduced social distancing behavior during the COVID-19 pandemic

RSV surveillance activity summary. Florida Department of Health